Interacting Drugs |
Erythromycin (systemic) vs Antifungal Agents (Azole Derivatives, Systemic) |
Security Level |
 |
Mechanism |
Antifungal Agents (Azole Derivatives, Systemic): May decrease the metabolism of Macrolide Antibiotics. Macrolide Antibiotics may decrease the metabolism of Antifungal Agents (Azole Derivatives, Systemic). |
Management |
Consider therapy modification |
Erythromycin (systemic) vs Antifungal Agents (Azole Derivatives, Systemic)
Post Review about Erythromycin (systemic) vs Antifungal Agents (Azole Derivatives, Systemic) Click here to cancel reply.
Other Interactions of Erythromycin (systemic)
Other Interactions of Antifungal Agents (Azole Derivatives, Systemic)
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.